Ceribell, Inc

Ceribell produces the world’s first brain monitor for point-of-care seizure triage and treatment. Our groundbreaking technology enables healthcare providers to test for a suspected seizure and then deliver treatments within minutes. We are a rapidly growing venture capital-backed medical technology startup. Ceribell is being used in hundreds of community hospitals, large academic facilities and major IDN’s across the country. With extensive clinical validation of the effectiveness of our product and significant growth potential, all while we are pre-IPO, Ceribell is a fantastic career opportunity.